Building effective collaboration between health systems and the life sciences industry

References

• Brasil. 2003. “Forum de competitividade da cadeia produtiva farmaceutica.” Ministério do Desenvolvimento, Indústria e Comércio Exterior Secretaria do Desenvolvimento da Produção.
   Google Scholar
• Centro Brasileiro de Estudos de Saúde. 2014. “Manifesto em Defesa das PDP.” Accessed 26 December 2018. http://cebes.org.br/site/wp-content/uploads/2014/08/Manifesto-entidades-CIS-jun-2014.pdf.
   Google Scholar
• Chaves, G., C. Osorio-de-Castro, and M. Auxiliadora Oliveira. 2017. “Compras públicas de medicamentos para hepatite C no Brasil no período de 2005 a 2015.” Ciência & Saúde Coletiva 22: 2527–2538. doi: 10.1590/1413-81232017228.05602017
   PubMedGoogle Scholar
• Department of Health and Social Care. 2018. Voluntary Scheme for Branded Medicines Pricing and Access: Heads of Agreement. London: Department of Health and Social Care.
   Google Scholar
• Fonseca, E. 2018. “How Can a Policy Foster Local Pharmaceutical Production and Still Protect Public Health? Lessons From the Health–Industry Complex in Brazil.” Global Public Health 13 (4): 489–502. doi: 10.1080/17441692.2017.1396354
   PubMed Web of Science ®Google Scholar
• Gadelha, C. 2006. “Desenvolvimento, Complexo Industrial da Saúde e Política Industrial.” Revista de Saúde Pública 40: 11–23. doi: 10.1590/S0034-89102006000400003
   PubMedGoogle Scholar
• House of Lords. 2018a. Life Sciences Industrial Strategy: Who’s Driving the Bus? London: Science and Technology Committee, House of Lords.
   Google Scholar
• House of Lords. 2018b. “Select Committee on Science and Technology - Corrected oral evidence: Life Sciences and the Industrial Strategy - 23 January 2018.” Accessed 24 December 2018. http://data.parliament.uk/writtenevidence/committeeevidence.svc/evidencedocument/science-and-technology-committee-lords/life-sciences-and-the-industrial-strategy/oral/77544.html.
   Google Scholar
• Kaplan, W. 2011. Local Production and Access to Medicines in Low- and Middle-Income Countries: a Literature Review and Critical Analysis. Geneva: WHO Department of Public Health, Innovation and Intellectual Property.
   Google Scholar
• Ministerio da Saude. 2014. Parcerias para o Desenvolvimento Produtivo - PDP. Brasília: Ministerio da Saude.
   Google Scholar
• Moye-Holz, D., J. van Dijk, S. Reijneveld, and H. Hogerzeil. 2017. “Policy Approaches to Improve Availability and Affordability of Medicines in Mexico – an Example of a Middle Income Country.” Globalization and Health 13 (53): 1–10.
   PubMedGoogle Scholar
• Naci, H., and E. Mossialos. 2017. “Accelerated Access to new Drugs and Technologies.” British Medical Journal 359 (j5387): 1–2.
   Google Scholar
• Office for Life Sciences. 2018. Life Science Competitiveness Indicators 2018. London: Department for Business, Energy and Industrial Strategy. Accessed 23 February 2019. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/706963/life-sciences-competitiveness-indicators-2018.pdf.
   Google Scholar
• Patton, M. 2001. “Evaluation, Knowledge Management, Best Practices, and High Quality Lessons Learned.” American Journal of Evaluation 22 (3): 329–336. doi: 10.1177/109821400102200307
   Web of Science ®Google Scholar
• Rodrik, D. 2008. “Normalizing Industrial Policy.” Commission on Growth and Development Working Paper No. 3. Washington, DC: The International Bank for Reconstruction and Development/The World Bank.
   Google Scholar
• Secretaria Federal de Controle Interno. 2017. Relatorio Anual de Auditoria: Unidade Auditada: Fundação Oswaldo Cruz. Brasilia: Controladoria Geral da Uniao.
   Google Scholar
• Shadlen, K., and E. Fonseca. 2013. “Health Policy as Industrial Policy: Brazil in Comparative Perspective.” Politics and Society 41 (4): 561–587. doi: 10.1177/0032329213507552
   Web of Science ®Google Scholar
• Silva, G., and F. Elias. 2017. “Parcerias para o desenvolvimento produtivo: um estudo de avaliabilidade.” Com. Ciências Saúde 28 (2): 125–139.
   Google Scholar
• Srinivas, S. 2012. Market Menagerie: Health and Development in Late Industrial States. Stanford: Stanford University Press.
   Google Scholar
• Thomas, L. 1994. “Implicit Industrial Policy: The Triumph of Britain and the Failure of France in Global Markets.” Industrial and Corporate Change 3 (2): 451–489. doi: 10.1093/icc/3.2.451
   Google Scholar
• United Nations Conference on Trade and Development. 2011. Local Production of Pharmaceuticals and Related Technology Transfer in Developing Countries: A Series of Case Studies by the UNCTAD Secretariat. Geneva: United Nations Conference on Trade and Development and World Health Organization.
   Google Scholar
• Valor Economico. 2016. “Valor Setorial: Saude”.
   Google Scholar
• World Bank. 2013. “The Impact of Universal Coverage Schemes in the Developing World: A Review of the Existing Evidence.” Universal Health Coverage Studies Series No. 25. Washington, DC: World Bank.
   Google Scholar
• World Health Assembly. 2008. “Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property.” In Resolution WHA61.21, 31–32. Geneva: World Health Organization.
   Google Scholar